A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00363896 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

843

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Aclidinium bromide
DRUG: Placebo

Sponsor

AstraZeneca